Andrada Mining acquisition elevates the miner to emerging mid-tier status. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,526.00
Bid: 1,525.50
Ask: 1,526.00
Change: -73.50 (-4.60%)
Spread: 0.50 (0.033%)
Open: 1,503.50
High: 1,532.00
Low: 1,484.00
Prev. Close: 1,599.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Britain's FTSE edges down ahead of growth data, RBS soars

Fri, 25th Jul 2014 08:19

* FTSE 100 down 0.1 pct, investor sentiment muted onearnings

* Q2 GDP data in focus after IMF upgrades

* RBS jumps 14 pct, biggest one-day gain in four years

* BSkyB deal hits shares, Burberry weaker on LVMH

LONDON, July 25 (Reuters) - UK shares edged lower in earlytrading on Friday, ahead of second quarter GDP data, asinvestors digested a raft of corporate results and Royal Bank ofScotland enjoyed an unexpected pop from earnings.

Investor sentiment was muted across Europe, held back bydisappointing earnings on both sides of the Atlantic and by athird consecutive monthly fall in the widely followed German Ifosurvey of business sentiment.

Merger activity also dominated early trading, with BSkyB agreeing to pay 4.9 billion pounds ($8.3 billion) incash to buy Rupert Murdoch's pay-TV assets in Germany and Italy.Construction companies Balfour Beatty and Carillion rallied after confirming merger talks.

The FTSE 100 index was down 0.1 percent, slightly betterthan Germany's DAX and the French CAC 40, whilethe pan-European FTSEurofirst 300 was down 0.2 percent.

A preliminary reading of second quarter British grossdomestic product was in focus after the International MonetaryFund this week upgraded its forecasts for the UK economy.

"Today's first iteration of Q2 GDP could well be a goodindicator of how well the UK economy is shaping up for the restof the year," CMC Markets analyst Michael Hewson said.

Shares of RBS soared 14.5 percent, their biggest intradaygain in at least four years, after the lender released earningsa week early that were much better than expected.

Network operator Vodafone was also up 2.2 percentafter saying its performance had begun to stabilise in severalEuropean markets even as a slowdown in Spain and South Africaled to another heavy drop in its key revenue measure.

Meanwhile, BSkyB fell 2.4 percent, the worst performer onthe FTSE 100, with traders citing the placement of sharesrepresenting around 10 percent of the company's capital to helppay for its announced asset purchases.

Burberry fell 1.9 percent after French luxury goodsgroup LVMH posted below-forecast second quarter salesand profits, hit by a drop in demand from China.

Another heavy faller was drugmaker GlaxoSmithKline,down 1.8 percent. The company faces new allegations ofcorruption, this time in Syria, where the drugmaker and itsdistributor have been accused of paying bribes to securebusiness, according to a whistleblower's email.

Publisher Pearson posted a 41 percent slump infirst-half profit, reflecting increased restructuring charges,currency movements and phasing in of revenues into the secondhalf, though an increased dividend helped the stock tradehigher. (Reporting by Lionel Laurent; Editing by Catherine Evans)

More News
12 Feb 2024 08:35

TOP NEWS: GSK's bepirovirsen receives US FDA fast track designation

(Alliance News) - GSK PLC on Monday said that the US health watchdog granted fast track designation for its bepirovirsen treatment for chronic hepatitis B.

Read more
12 Feb 2024 07:50

LONDON BRIEFING: Tritax Big Box, UK Commercial Property agree merger

(Alliance News) - Equities in London are called to open higher on Monday, with inflation readings from the US and UK on the horizon, which could drive equity market sentiment during the remainder of the week.

Read more
12 Feb 2024 07:21

GSK gets FDA fast track for chronic hepatitis B treatment

(Sharecast News) - GSK announced on Monday that bepirovirsen, an investigational antisense oligonucleotide (ASO) aimed at treating chronic hepatitis B (CHB), had been granted fast track designation by the US Food and Drug Administration (FDA).

Read more
9 Feb 2024 09:15

LONDON BROKER RATINGS: Deutsche Bank cuts AstraZeneca to 'sell'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
6 Feb 2024 08:51

TOP NEWS: GSK reports positive news on trio of high profile products

(Alliance News) - GSK PLC on Tuesday delivered a triple dose of positive updates on some of its leading products, Arexvy, Shingrix and Blencep.

Read more
6 Feb 2024 07:47

LONDON BRIEFING: BP promises buyback despite drop in profit

(Alliance News) - Stocks in London are called to open higher, ahead of a slew of construction purchasing managers' index readings from the eurozone, the UK and Germany.

Read more
6 Feb 2024 07:23

GSK reports positive myeloma trial results, progresses vaccine applications

(Sharecast News) - GSK reported progress in its trial of a myeloma treatment on Tuesday, as well as regulatory progress around its shingles vaccine in China and its RSV vaccine in the United States.

Read more
1 Feb 2024 09:27

TOP NEWS: GSK maintains "vigorous" defence after settling Zantac case

(Alliance News) - GSK PLC on Thursday insisted upon its scientific integrity, after reaching another settlement in ongoing litigation over alleged links between its heartburn drug and cancer.

Read more
1 Feb 2024 09:11

GSK settles Zantac case in California without admitting liability

(Sharecast News) - GSK announced on Thursday that it had reached a confidential settlement to effectively resolve the legal case over Zantac filed in a California state court.

Read more
1 Feb 2024 09:03

LONDON BROKER RATINGS: Barclays cuts Next; JPMorgan raises easyJet

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning:

Read more
1 Feb 2024 07:42

LONDON BRIEFING: Shell profit falls; announces USD3.5 billion buyback

(Alliance News) - Stocks in London are set to follow New York into the red, after the US Federal Reserve quashed hopes of a March cut to interest rates and ahead of the Bank of England interest rate decision.

Read more
31 Jan 2024 17:05

LONDON MARKET CLOSE: Stocks mixed hours before expected US Fed hold

(Alliance News) - Stock prices in London closed mixed on Wednesday in a trade-thinned day ahead of the US Federal Reserve interest rate decision this evening.

Read more
31 Jan 2024 15:49

London close: Stocks mixed ahead of US Fed, BoE decisions

(Sharecast News) - London's financial markets finished with mixed performance on Wednesday, with investors closing their wallets ahead of rate announcements from both the US Federal Reserve and the Bank of England.

Read more
31 Jan 2024 12:05

LONDON MARKET MIDDAY: FTSE 100 flat ahead of Federal Reserve decision

(Alliance News) - The FTSE 100 in London was flat heading into Wednesday afternoon, as the US Federal Reserve's latest interest rate decision edges closer, keeping equity market enthusiasm to a minimum.

Read more
31 Jan 2024 09:13

TOP NEWS: GSK profit up on Arexvy boost in 2023 but total payout down

(Alliance News) - GSK PLC reported an increase in profit and revenue for 2023 as revenue for HIV medicine had stable growth, amid optimism in the company's outlook.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.